^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

tyrphostin (AG 490)

i
Other names: AG 490
Associations
Trials
Company:
EMD Serono, Hebrew University of Jerusalem, Pfizer, Yissum Research Development Company
Drug class:
JAK2 inhibitor
Associations
Trials
1year
Kaempferol activates chloride secretion via the cAMP/PKA signaling pathway and expression of CFTR in T84 cells. (PubMed, Front Pharmacol)
Ion substitution of Cl- or CFTR inhibitors NPPB and glibenclamide or a Na+/K+/2Cl- cotransporter inhibitor bumetanide attenuated kaempferol-induced I sc response...The kaempferol-induced I Cl was mostly abolished by protein kinase A inhibitor H89, but not by tyrosine kinase inhibitors, AG490 and tyrphostin A23, or tyrosine phosphatase inhibitor vanadate...The mechanisms may involve the cAMP/PKA pathway and CFTR expression. Taken together, these findings reveal the beneficial effects of kaempferol to increase fluid secretion which can be used to treat constipation.
Journal
|
CFTR (CF Transmembrane Conductance Regulator)
|
CFTR expression
|
tyrphostin (AG 490)
over1year
Breviscapine ameliorates autophagy by activating the JAK2/STAT5/BCL2 pathway in a transient cerebral ischemia rat model. (PubMed, J Neuropathol Exp Neurol)
Rats were randomly divided into 5 groups, i.e. Sham group, MCAO+saline group, MCAO+Bre group, MCAO+DMSO (Dimethyl sulfoxide) group, and MCAO+Bre+AG490 (Tyrphostin AG490, the inhibitor of STAT5) group...The JAK2 inhibitor AG490 reversed these effects. These findings indicate that breviscapine can improve neural recovery following ischemia through alleviating excessive autophagy and activation of the JAK2/STAT5/BCL2 axis.
Preclinical • Journal • IO biomarker
|
BECN1 (Beclin 1)
|
tyrphostin (AG 490)
over4years
CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway. (PubMed, Front Oncol)
The inhibitor AG490 of JAK-STAT signaling pathway was used to identify the functional mechanism of CXCL1/JAK-STAT underlying progression of CRC, and tumor xenograft experiments were performed for further validation...CXCL1 could be regulated by miR-302e to inactivate JAK-STAT signaling pathway, in turn affecting cell proliferation, migration, invasion, and apoptosis of CRC. Our result provides a potential therapeutic target for CRC treatment.
Journal
|
CXCL1 (Chemokine (C-X-C motif) ligand 1) • MIR30E (MicroRNA 30e)
|
miR-30e expression
|
tyrphostin (AG 490)
over4years
Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity. (PubMed, Nutrients)
The link between the decrease in phosphorylated STAT3 by MBS and IBS and BCL1 cell death was confirmed by detection of enhanced cell death after addition of AG490, an inhibitor of Jak2 kinase. It seems that IBS and MBS, by decreasing STAT3 phosphorylation, trigger apoptosis, inhibit cell proliferation, and attenuate leukemia cell stemness.
Journal
|
CCND1 (Cyclin D1)
|
tyrphostin (AG 490)
over4years
EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype. (PubMed, Molecules)
This invasive phenotype was prevented by EGCG, the JAK/STAT inhibitors Tofacitinib and AG490, as well as upon STAT3 gene silencing. In conclusion, dietary catechin-mediated interventions could, in part through the inhibition of adipogenesis and modulation of adipocytes secretome profile, prevent the onset of an obesogenic environment that favors TNBC development.
Journal
|
STAT3 (Signal Transducer And Activator Of Transcription 3) • FASN (Fatty acid synthase) • LPL (Lipoprotein Lipase)
|
tofacitinib • tyrphostin (AG 490)
over4years
New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma Cells. (PubMed, Int J Mol Sci)
Four out of the 14 derivatives were shown to inhibit hepatoma cell proliferation at (sub-)micromolar concentrations with IC values below that of the clinically relevant multikinase inhibitor sorafenib, which served as a reference...Additional bioinformatic analysis of the VEGFR-2 binding modes by docking and molecular dynamics calculations supported the experimental findings and indicated that the hydroxy group of 1c might be crucial for its distinct inhibitory potency against VEGFR-2. Forthcoming studies will further unveil the underlying mode of action of the promising new derivatives as well as their suitability as an urgently needed novel approach in HCC treatment.
Journal
|
KDR (Kinase insert domain receptor)
|
sorafenib • tyrphostin (AG 490)
almost5years
Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment. (PubMed, Int J Mol Sci)
By retrospective analysis of NSCLC patient tissues obtained from the tumor biobank; pre-clinical studies with Hiltonol alone or Hiltonol cocktail [Hiltonol+anti-IL6+AG490 (JAK2 inhibitor)+Stattic (STAT3 inhibitor)]; cytokine analysis; gene knockdown and gain/loss-of-function studies, we uncovered the mechanisms of action of Hiltonol. Ex vivo analysis of NSCLC patient tissues corroborated that loss of PKR and OAS is associated with cancer advancement. Altogether, our findings unraveled the significance of studying tumor biobank tissues, which suggests PKR and OAS as precision oncological suppressor candidates to be targeted by this novel Hiltonol cocktail which represents a prospective drug for development into a potent and tailored therapy for NSCLC subtypes.
Journal
|
CXCL8 (Chemokine (C-X-C motif) ligand 8) • CASP3 (Caspase 3) • CASP9 (Caspase 9)
|
Hiltonol (poly-ICLC) • tyrphostin (AG 490)
almost5years
Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway. (PubMed, Eur Rev Med Pharmacol Sci)
Losartan promotes myocardial apoptosis after AMI in the rats through inhibiting the Ang II-induced JAK/STAT pathway.
Preclinical • Journal • IO biomarker
|
STAT3 (Signal Transducer And Activator Of Transcription 3) • BAX (BCL2-associated X protein)
|
BAX expression
|
tyrphostin (AG 490)
almost5years
Induction of proliferative and mutagenic activity by benzo(a)pyrene in PC-3 cells via JAK2/STAT3 pathway. (PubMed, Mutat Res)
Significant reductions in cell survival, mutagenic activity, Cyclin D1, CDK4, Snail, and JAK2/STAT3 expression were found after inhibitor AG490, ANF and CHJ223191 treatment. These findings reveal that BaP enhances the proliferative and mutagenic activity via JAK2-STAT3 pathway in PC-3 cells, and provide the additional evidence to understand the crucial role of BaP in prostate cancer carcinogenesis.
Journal
|
CCND1 (Cyclin D1) • IL6 (Interleukin 6) • CDK4 (Cyclin-dependent kinase 4) • CDH1 (Cadherin 1) • MMP9 (Matrix metallopeptidase 9) • CYP1A1 (Cytochrome P450 Family 1 Subfamily A Member 1)
|
CCND1 expression • STAT3 expression • CDK4 mutation
|
tyrphostin (AG 490)
almost5years
Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition mediated by interleukin-6/signal transducer and activator of transcription 3/Snail pathway in the H22 cells. (PubMed, J Cancer Res Ther)
AG490, an IL-6 inhibitor, inhibited the occurrence of EMT. Insufficient ablation performed at low temperature successfully induces EMT and promotes tumor aggressiveness, which is mediated by the IL-6/STAT3/Snail pathway in both cell and mouse models.
Journal
|
IL6 (Interleukin 6) • CDH1 (Cadherin 1) • STAT3 (Signal Transducer And Activator Of Transcription 3) • VIM (Vimentin)
|
tyrphostin (AG 490)
5years
Pasteurized Chicken Egg Powder Stimulates Proliferation and Migration of AGS, RIE1, and Caco-2 Cells and Reduces NSAID-Induced Injury in Mice and Colitis in Rats. (PubMed, J Nutr)
Studies using AGS, RIE1, and Caco-2 cells, C57BL/6 mice, and Sprague Dawley rats showed protective effects of egg against gut injury. Enhanced results were seen if colostrum and egg were coadministered. Egg powder with or without colostrum may have therapeutic value for prevention and treatment of gut injuries.
Preclinical • Journal
|
EGFR (Epidermal growth factor receptor)
|
tyrphostin (AG 490)